Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Response to Comment Virginie DufrostJessie RisseStéphane Zuily Letters to the Editor 24 July 2017 Article: 52
How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated Scores Kenji OkuOlga AmengualTatsuya Atsumi Antiphospholipid Syndrome (S Zuily, Section Editor) 24 July 2017 Article: 51
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Comment Hannah CohenBeverley J. HuntOn behalf of the RAPS Trial Investigators Letters to the Editor Open access 20 July 2017 Article: 50
Contribution of Circulatory Disturbances in Subchondral Bone to the Pathophysiology of Osteoarthritis Roy K. AaronJennifer RacineJonathan P. Dyke Osteoarthritis (M Goldring, Section Editor) 17 July 2017 Article: 49
New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus Marc ScherlingerVanja SisirakPatrick Blanco Systemic Lupus Erythematosus (G Tsokos, Section Editor) 17 July 2017 Article: 48
Update on Biosimilars in Asia Wen-Chan Tsai Biosimilars (E Mysler, Section Editor) 17 July 2017 Article: 47
Schnitzler Syndrome: a Review L. GusdorfD. Lipsker Orphan Diseases (B Manger, Section Editor) 17 July 2017 Article: 46
Innate Immune Responses and Osteoarthritis Evangelia KalaitzoglouTimothy M. GriffinMary Beth Humphrey Osteoarthritis (M Goldring, Section Editor) 17 July 2017 Article: 45
Recent Advances in Tissue Engineering Strategies for the Treatment of Joint Damage Makeda K. StephensonAshley L. FarrisWarren L. Grayson Osteoarthritis (M Goldring, Section Editor) 17 July 2017 Article: 44
